Epidemic hemorrhagic fever (EHF) refers to a group of diseases characterized by fever, bleeding, and multi-system organ failure. The most well-known EHF diseases include Ebola virus disease, Lassa fever, Marburg virus disease, and Crimean-Congo hemorrhagic fever. Each of these diseases has its own unique epidemiological characteristics, but they share similarities in terms of transmission routes, affected populations, and impact on different regions.

Historical Context and Discovery:
EHF diseases have been known to exist for centuries, but the understanding and recognition of these diseases as distinct entities have evolved over time. For example, Ebola virus disease was first identified in 1976 during two simultaneous outbreaks in Sudan and the Democratic Republic of Congo (formerly Zaire). Similarly, Lassa fever was discovered in 1969 in Nigeria. The identification and study of these diseases have been crucial in understanding their epidemiology and developing strategies for prevention and control.

Global Prevalence:
EHF diseases are primarily found in tropical and sub-tropical regions of Africa, Asia, and South America. The prevalence of these diseases varies geographically, with some regions experiencing periodic outbreaks while others have endemic transmission. For example, Ebola virus disease is primarily found in Central and West Africa, while Lassa fever is endemic in West Africa. Marburg virus disease has been reported in several African countries, and Crimean-Congo hemorrhagic fever is prevalent in parts of Africa, Asia, and Europe.

Transmission Routes:
The primary mode of transmission for EHF diseases is through direct contact with the bodily fluids (such as blood, saliva, urine, and feces) of infected individuals or animals. This can occur through activities like caring for the sick, handling infected animals, or participating in traditional burial practices. In some cases, EHF diseases can also be transmitted through contaminated objects or surfaces. Additionally, certain EHF diseases can be transmitted from animals (such as bats, rodents, and non-human primates) to humans, leading to zoonotic outbreaks.

Affected Populations:
EHF diseases can affect individuals of all ages and genders. However, certain populations may be at increased risk due to occupational or behavioral factors. Healthcare workers, laboratory personnel, and individuals involved in animal husbandry or wildlife trade are at higher risk of exposure to EHF diseases. Additionally, communities with limited access to healthcare, poor sanitation, and inadequate infection control measures are more vulnerable to outbreaks.

Key Statistics:
EHF diseases have a high case fatality rate, ranging from 20% to 90% depending on the specific disease and outbreak context. The number of reported cases and deaths varies annually, with periodic outbreaks causing significant morbidity and mortality. For instance, the 2014-2016 Ebola outbreak in West Africa resulted in over 28,000 cases and more than 11,000 deaths. Similarly, Lassa fever causes thousands of cases each year in West Africa, with a case fatality rate of around 1%.

Major Risk Factors:
Several risk factors contribute to the transmission of EHF diseases. These include lack of awareness about the diseases and their transmission routes, inadequate infection prevention and control practices in healthcare settings, and limited resources for surveillance and response. Additionally, cultural practices and traditional beliefs related to handling of dead bodies, hunting, and consumption of bushmeat can increase the risk of exposure to these diseases.

Impact on Different Regions and Populations:
EHF diseases have a significant impact on the regions where they occur. Outbreaks can lead to social and economic disruptions, strain healthcare systems, and cause fear and stigmatization within affected communities. The impact on different populations can vary based on factors such as access to healthcare, education, and socioeconomic status. Additionally, some EHF diseases may disproportionately affect certain age groups or populations with underlying health conditions, making them more vulnerable to severe illness and death.

In conclusion, epidemic hemorrhagic fever diseases have a global prevalence, primarily affecting tropical and sub-tropical regions. These diseases are transmitted through direct contact with bodily fluids of infected individuals or animals. Certain populations, such as healthcare workers and communities with limited resources, are at higher risk. EHF diseases have a high case fatality rate and can cause significant morbidity and mortality. Implementation of effective prevention and control measures, along with strengthening healthcare systems and public health infrastructure, is crucial in reducing the impact of EHF diseases.